News
Tag: Financial & Investor News
-
Achieve Life Sciences Announces Granting of New Hire Inducement Award
SEATTLE, Wash. and VANCOUVER, British Columbia, March 17, 2023 — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that the Company has issued an inducement grant of stock options to a new employee. Achieve’s Board of…
-
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2022 and Provides Corporate Update
Company to host conference call March 16, 2023, at 4:30 PM EDT. SEATTLE, Wash and VANCOUVER, British Columbia, Mar. 16, 2023 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced fourth quarter and…
-
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call and Webcast on March 16, 2023
SEATTLE, WA and VANCOUVER, British Columbia, March 2, 2023 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced it will report its fourth quarter and year-end 2022 financial results and provide an update…
-
Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference
SEATTLE, Wash. and VANCOUVER, British Columbia, Feb. 2, 2023 — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it will participate in one-on-one meetings during the 2023 SVB Securities Global Biopharma Conference. The conference is…
-
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
SEATTLE, Wash. and VANCOUVER, British Columbia, Jan. 27, 2023 — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that the Company has issued an inducement grant of stock options to a new employee. Achieve’s Board of…